Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Wright Medical Group Inc    

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Wright Medical Group, Inc. : to Host First Quarter 2012 Earnings Conference Call

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/13/2012 | 01:05am CET

Tuesday, May 1, 2012 at 3:30 p.m. Central/4:30 p.m. Eastern

Wright Medical Group, Inc. (NASDAQ: WMGI) today announced that it will host a conference call on Tuesday, May 1, 2012 at 3:30 p.m. Central Time to discuss the Company's operating results for its first quarter ended March 31, 2012. Operating results will be released at 3:00 p.m. Central Time that day.

The live dial-in number for the call is 800-659-2032 (U.S.) / 617-614-2712 (International). The participant passcode for the call is "Wright." A simultaneous webcast of the call will be available via Wright Medical's corporate website at www.wmt.com. The call will also be archived on this site for a minimum of 12 months.

A recording of the call will be available beginning at 5:30 p.m. Central Time on May 1, 2012 through May 8, 2012. To hear this recording, dial 888-286-8010 (U.S.) / 617-801-6888 (International) and enter code 47749217.

About Wright Medical

Wright Medical Group, Inc. is a global orthopaedic medical device company and a leading provider of surgical solutions for the foot and ankle market. The Company specializes in the design, manufacture and marketing of devices and biologic products for extremity, hip and knee repair and reconstruction. The Company has been in business for 60 years and markets its products in over 60 countries worldwide. For more information about Wright Medical, visit the Company's website at www.wmt.com.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

The conference call and webcast may contain "forward-looking statements" as defined under U.S. federal securities laws. These statements reflect management's current knowledge, assumptions, beliefs, estimates, and expectations and express management's current views of future performance, results, and trends and may be identified by their use of terms such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "plan," "predict," "project," "will," and other similar terms. Forward-looking statements are subject to a number of risks and uncertainties that could cause our actual results to materially differ from those described in the forward-looking statements. Such risks and uncertainties include the impact of Wright's settlement of the federal investigation into Wright's consulting arrangements with orthopaedic surgeons relating to its hip and knee products in the United States, including Wright's compliance with a Deferred Prosecution Agreement through September 2012 and a Corporate Integrity Agreement through September 2015, and those risks and uncertainties discussed in our filings with the Securities and Exchange Commission (including those described in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2011, under the heading, "Risk Factors"), including demand for and market acceptance of our new and existing products; future actions of governmental authorities and other third parties; tax measures; business development and growth opportunities; product quality or patient safety issues; products liability claims; enforcement of our intellectual property rights; the geographic and product mix impact on our sales; retention of sales representatives and independent distributors; inventory reductions or fluctuations in buying patterns by wholesalers or distributors; ability to realize the anticipated benefits of restructuring initiatives; and impact of the commercial and credit environment on us and our customers and suppliers. Readers should not place undue reliance on forward-looking statements.

Wright Medical Group, Inc.
Investors & Media:
Julie D. Tracy, 901-290-5817
Sr. Vice President, Chief Communications Officer
julie.tracy@wmt.com


© Business Wire 2012
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on WRIGHT MEDICAL GROUP INC
2015 Wright Medical Group N.V. to Present at 34th Annual J.P. Morgan Healthcare Co..
2015 Wright Medical Group N.V. Announces Secondary Offering of 4.5 Million Ordinar..
2015 Wright Medical Group N.V. to Present at the Piper Jaffray Healthcare Conferen..
2015 Wright Medical Group N.V. Reports 2015 Third Quarter Financial Results
2015 Wright Medical Group N.V. to Present at the Credit Suisse 2015 Healthcare Con..
2015 Wright Medical Group N.V. to Present at the Jefferies Autumn 2015 Global Heal..
2015 Wright Medical Group N.V. to Host Third Quarter 2015 Earnings Conference Call
2015 Wright Medical and Tornier Complete Merger and Create Premier High-Growth Ext..
2015 Wright Medical Group, Inc. Announces FDA Approval for AUGMENT(R) Bone Graft
2015 Wright Medical Group, Inc. to Present at Baird 2015 Healthcare Conference
More news
Sector news : Medical Prosthetics
11/22DJMEDTRONIC : Cuts Guidance on Sluggish Revenue
11/22DJMEDTRONIC : Cuts Guidance on Sluggish Revenue -- 2nd Update
11/22DJMEDTRONIC : Cuts Guidance on Sluggish Revenue
11/15 EXCLUSIVE : EU regulators seen clearing $25 billion Abbott, St Jude deal
11/15 Exclusive - EU regulators seen clearing $25 billion Abbott, St Jude deal
More sector news : Medical Prosthetics
News from SeekingAlpha
2015 Wright Medical and Tornier complete merger
2015 PREMARKET GAINERS / LOSERS AS OF 9 : 10 am
2015 PREMARKET BIOTECH DIGEST : Anti-CD Antigen Therapy, Geron Files S-3, 3 MAAs In E..
2015 After Hours Gainers / Losers
2015 FDA clears Wright's AUGMENT Bone Graft
Advertisement
Financials ($)
Sales 2015 330 M
EBIT 2015 -73,3 M
Net income 2015 -124 M
Debt 2015 283 M
Yield 2015 -
P/E ratio 2015 -
P/E ratio 2016
EV / Sales 2015 4,19x
EV / Sales 2016 3,57x
Capitalization 1 099 M
More Financials
Chart WRIGHT MEDICAL GROUP INC
Duration : Period :
Wright Medical Group Inc Technical Analysis Chart | US98235T1079 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 15
Average target price 30,5 $
Spread / Average Target 43%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Robert J. Palmisano President, Chief Executive Officer & Director
David D. Stevens Chairman
David H. Mowry Chief Operating Officer & Executive Vice President
Lance A. Berry Chief Financial Officer & Senior Vice President
John Raney Chief Information Officer & Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
WRIGHT MEDICAL GROUP I..-13.90%0
SONOVA HOLDING AG-4.71%7 848
STRAUMANN HOLDING AG19.51%5 716
COCHLEAR LIMITED23.58%5 006
INSULET CORPORATION-11.88%1 913
REWALK ROBOTICS LTD-81.00%44
More Results